Skip Navigation
Skip Ribbon Commands
Skip to main content
NIAID > Topics > Vaccines

Vaccines

Vaccine Research

Vaccines provide safe, cost-effective, and efficient means of preventing illness, disability, and death from infectious diseases. NIAID conducts and supports research on new and improved vaccines and is a worldwide leader in the basic immunology research that underpins all vaccine research and development.

NIAID Research

Highlights

Chinnaswamy Jagannath, Ph.D. Woman giving injection to child
 

The Jordan Report: Accelerated Development of Vaccines 2012

Videocast: HHS Science Seminar for Media—Advances in Influenza Vaccine Technologies

NIAID’s network of Vaccine and Treatment Evaluation Units (VTEUs)

NIAID Lab Developing Intranasal RSV Vaccines

NIAID Scientists Use Reverse Genetics to Develop Potential Dengue Vaccine

Flu Shots No More? NIAID Grantees Use New Skin Patches to Deliver Flu Vaccine in Mice

Program Announcement

Research to Advance Vaccine Safety (R01 and R21)

News and Events

Possible Clues Found to Why HIV Vaccine Showed Modest Protection—April 4, 2012

Media Availability: NIH Tests Novel Vaccine Made from Weakened Malaria Parasites—Jan. 19, 2012

Media Availability: Experimental Vaccine Partially Protects Monkeys from HIV-Like Infection—Jan. 4, 2012

Chikungunya Vaccine Trial Begins Enrollment—Dec. 20, 2011

NIH Videocast: Communicating Vaccine Science to the Public—Dec. 14, 2011

NIH Videocast: 2011 Kinyoun Lecture – A Public Health Approach to Infectious Disease Prevention and Control for the 21st Century—Nov. 17, 2011

All vaccine news and events

News from NIAID-Supported Institutions

Last Updated April 04, 2012

Last Reviewed April 29, 2011